Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Absence of SLC22A12/URAT1 Gene Mutations in Patients with Primary Gout

ROSA J. TORRES, EUGENIO DE MIGUEL, REBECA BAILEN and JUAN G. PUIG
The Journal of Rheumatology September 2012, 39 (9) 1901; DOI: https://doi.org/10.3899/jrheum.120451
ROSA J. TORRES
Clinical Biochemistry Division;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rtorres.hulp@salud.madrid.org
EUGENIO DE MIGUEL
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
REBECA BAILEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUAN G. PUIG
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

In most patients with primary gout, hyperuricemia has been related to a decreased urinary uric acid excretion, but the specific gene abnormalities that may cause an impaired tubular transport of urate are unknown. The first urate transporter described was SLC22A12/URAT11. Mutations in the SLC22A12/URAT1 gene have been associated to primary renal hypouricemia type I (OMIN 220150) in several populations1,2,3,4,5, although some ethnic differences may explain the lack of association between this gene and primary renal hypouricemia in other populations such as Greek whites6. Because this transporter reabsorbs urate from the renal tubule, loss of function mutations may cause renal urate wasting and hypouricemia. However, it has been reported that among 69 Mexican patients with primary gout, 16 (23%) showed 6 different SLC22A12/URAT1 mutations7. Could these mutations explain hyperuricemia due to impaired renal uric acid excretion? Although none of these mutations was segregated in the 240 chromosomes of healthy individuals7, no study has confirmed or refuted SLC22A12/URAT1 mutations in patients with gout, and it is uncertain whether an enhanced tubular reabsorption of urate may cause hyperuricemia. Notably, one of these mutations has also been associated with primary renal hypouricemia type I7.

In an extensive series of white patients with primary gout, we have determined whether the previously reported SLC22A12/URAT1 gene mutations in Mexican patients with gout, or other mutations in this gene, could explain their increased serum urate concentrations.

Seventy-seven patients with primary gout according to Wallace, et al8 criteria and who had had at least 2 acute gouty arthritis episodes were studied at the metabolic and vascular unit of La Paz University Hospital, Madrid, Spain. All studies were conducted according to the Declaration of Helsinki, and were approved by the Institutional Research and Ethics Review Committees of La Paz University Hospital. Among the 77 patients with gout, 73 were men (95%). Their mean age (± SD) was 59.8 ± 9.1 years. Mean serum urate concentration was 8.2 ± 1.5 mg/dl and 24-h uric acid excretion was 455 ± 111 mg/24 h/1.73 m2. All patients exhibited a decreased urinary uric acid excretion rate, according to their increased serum urate levels9.

RNA-free genomic DNA samples from patients with gout were isolated from whole blood, and the 10 exons of the human SLC22A12/URAT1 gene were amplified by polymerase chain reaction with the gene’s flanking intron sequences. Strands (forward and reverse) of the amplified DNA fragments were sequenced in an ABI Prism 377 DNA Sequencer (Applied Biosystems, Foster City, CA, USA).

Both forward and reverse sequences were successful and consistent. Genetic analysis detected no mutations in the SLC22A12/URAT1 gene, except for the previously reported silent polymorphisms rs 3825016, 11231825, 1630320, 7932775, and the intronic polymorphism rs 79866595. In this regard, in recent years serum uric acid has been associated with several single-nucleotide polymorphisms (SNP) of different genes, mainly by genome-wide association studies (GWAS). SNP in SLC22A12/URAT1 were first associated with hyperuricemia in white, Japanese, and Italian cohorts. Association was replicated in other GWAS in population-based cohorts10, although this contributes only modestly to explaining variability in serum urate.

The absence of SLC22A12/URAT1 coding sequence mutations in our Spanish patients with gout can best be interpreted to mean that their decreased uricosuria and hyperuricemia cannot be attributed to an abnormality in this transporter. However, a mutation in the noncoding sequence of this gene, or in other different genes, that may lead to increased amounts of URAT1 protein cannot be ruled out. A disturbance in other tubular urate transporters, such as ABCG2, which secretes urate into the tubular lumen, may contribute to reduce uric acid excretion and increase serum urate concentrations. We wonder whether the previously reported base substitutions in Mexican patients7 could be related to silent polymorphisms instead of gain-of-function mutations.

Footnotes

  • Supported by a grant from Fondo de Investigaciones Sanitarias (Healthcare Research Fund; FIS 08/0009).

REFERENCES

  1. 1.↵
    1. Enomoto A,
    2. Kimura H,
    3. Chairoungdua A,
    4. Shigeta Y,
    5. Jutabha P,
    6. Cha SH,
    7. et al.
    Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002;417:447–52.
    OpenUrlPubMed
  2. 2.↵
    1. Ichida K,
    2. Hosoyamada M,
    3. Hisatome I,
    4. Enomoto A,
    5. Hikita M,
    6. Endou H,
    7. et al.
    Clinical and molecular analysis of patients with renal hypouricemia in Japan — Influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004;15:164–73.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Cheong HI,
    2. Kang JH,
    3. Lee JH,
    4. Ha IS,
    5. Kim S,
    6. Komoda F,
    7. et al.
    Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr Nephrol 2005;20:886–90.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Dinour D,
    2. Bahn A,
    3. Ganon L,
    4. Ron R,
    5. Geifman-Holtzman O,
    6. Knecht A,
    7. et al.
    URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dial Transplant 2011;26:2175–81.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Sebesta I,
    2. Stiburkova B,
    3. Bartl J,
    4. Ichida K,
    5. Hosoyamada M,
    6. Taylor J,
    7. et al.
    Diagnostic tests for primary renal hypouricemia. Nucleosides Nucleotides Nucleic Acids 2011;30:1112–6.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Tzovaras V,
    2. Chatzikyriakidou A,
    3. Bairaktari E,
    4. Liberopoulos EN,
    5. Georgiou I,
    6. Elisaf M
    . Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia. Scand J Clin Lab Invest 2007;67:589–95.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Vázquez-Mellado J,
    2. Jiménez-Vaca AL,
    3. Cuevas-Covarrubias S,
    4. Alvarado-Romano V,
    5. Pozo-Molina G,
    6. Burgos-Vargas R
    . Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology 2007;46:215–9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Wallace SL,
    2. Robinson H,
    3. Masi AT,
    4. Decker JL,
    5. McCarty DJ,
    6. Yü T-F
    . Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895–900.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Puig JG,
    2. Torres RJ,
    3. de Miguel E,
    4. Sánchez A,
    5. Bailén R,
    6. Banegas JR
    . Uric acid excretion in healthy subjects: A nomogram to assess the mechanisms underlying purine metabolic disorders. Metabolism 2012;61:512–8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Kolz M,
    2. Johnson T,
    3. Sanna S,
    4. Teumer A,
    5. Vitart V,
    6. Perola M,
    7. et al.
    Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 9
1 Sep 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Absence of SLC22A12/URAT1 Gene Mutations in Patients with Primary Gout
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Absence of SLC22A12/URAT1 Gene Mutations in Patients with Primary Gout
ROSA J. TORRES, EUGENIO DE MIGUEL, REBECA BAILEN, JUAN G. PUIG
The Journal of Rheumatology Sep 2012, 39 (9) 1901; DOI: 10.3899/jrheum.120451

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Absence of SLC22A12/URAT1 Gene Mutations in Patients with Primary Gout
ROSA J. TORRES, EUGENIO DE MIGUEL, REBECA BAILEN, JUAN G. PUIG
The Journal of Rheumatology Sep 2012, 39 (9) 1901; DOI: 10.3899/jrheum.120451
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Dr Singer et al reply
  • Psychosocial Factors Significantly Contribute to Joint Pain Persistence in Psoriatic Arthritis
  • The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2023 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire